| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,665 |
7,002 |
$455K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,870 |
2,112 |
$202K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,456 |
1,767 |
$195K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,166 |
845 |
$92K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,768 |
2,752 |
$65K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
564 |
384 |
$49K |
| 90670 |
|
1,717 |
1,240 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
219 |
191 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
151 |
146 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
214 |
186 |
$11K |
| 90680 |
|
832 |
619 |
$8K |
| 87428 |
|
123 |
116 |
$8K |
| 90648 |
|
440 |
399 |
$7K |
| 90698 |
|
878 |
580 |
$6K |
| 90686 |
|
517 |
408 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
394 |
270 |
$5K |
| 87634 |
|
94 |
81 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
120 |
106 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
301 |
242 |
$5K |
| 90633 |
|
503 |
348 |
$4K |
| 90744 |
|
636 |
436 |
$4K |
| 90723 |
|
269 |
244 |
$4K |
| 90677 |
|
237 |
208 |
$4K |
| 99173 |
|
431 |
252 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
90 |
87 |
$3K |
| 83655 |
|
176 |
146 |
$2K |
| 90734 |
|
153 |
101 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
47 |
45 |
$2K |
| 90681 |
|
85 |
71 |
$1K |
| 90656 |
|
76 |
72 |
$1K |
| 90685 |
|
177 |
109 |
$1K |
| 99381 |
|
13 |
13 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
58 |
43 |
$940.53 |
| 87807 |
|
87 |
84 |
$855.10 |
| 90710 |
|
57 |
38 |
$783.23 |
| 90696 |
|
64 |
52 |
$527.99 |
| 90707 |
|
48 |
25 |
$315.76 |
| 90716 |
|
38 |
25 |
$251.30 |
| 90715 |
|
19 |
13 |
$198.43 |
| 85018 |
|
69 |
57 |
$162.44 |
| 90700 |
|
17 |
12 |
$115.19 |
| 87400 |
|
29 |
13 |
$95.50 |
| 90647 |
|
14 |
14 |
$92.48 |
| 88720 |
|
14 |
12 |
$61.60 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
32 |
19 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
33 |
17 |
$0.00 |